Associate Professor
University of Michigan
Ann Arbor, MI, United States
Dr. Rao attended medical school at Rush Medical College in Chicago, Illinois, and completed both his residency in internal medicine and his fellowship in infectious diseases at the University of Michigan. Dr. Rao’s clinical, administrative, and research interests include the diagnosis and management of healthcare-associated infections, especially Clostridium difficile infection. His clinical work includes managing the University of Michigan Fecal Microbiota Transplantation (stool transplant) program for recurrent Clostridium difficile infection, a program that he co-founded.
His primary research goal is to investigate how biochemical, microbiological, and clinical factors can help clinical decision-making in healthcare-associated infections, and he hopes to ultimately integrate these factors into robust risk-prediction algorithms for use by clinicians. His funding sources have included the NIH, CDC, industry, and non-profit foundations, and his projects include the study of C. difficile infection, the effect of antibiotics on the gut microbiota, and infections from Gram-negative bacteria, including multi-drug resistant organisms, such as Klebsiella pneumoniae.
A full bibliography and other details are available at:
https://orcid.org/0000-0002-9213-7850
Disclosure(s): Merck and Company, Inc.: Grant/Research Support; Rebiotix Inc.: Advisor/Consultant; Seres Therapeutics: Advisor/Consultant; Summit pharmaceuticals: Advisor/Consultant
23 - Building Your Own Clinical Prediction Model: A Bootcamp for the ID Researcher
Thursday, October 17, 2024
10:30 AM – 11:45 AM US PT
202 - Targeting Clostridioides difficile Infection Prevention Efforts with Artificial Intelligence
Thursday, October 17, 2024
3:15 PM – 3:30 PM US PT
95 - Advances and Controversies in Orthopedic Infections: A Multidisciplinary Discussion
Thursday, October 17, 2024
3:15 PM – 4:30 PM US PT